Cost-effectiveness of varenicline for smoking cessation. (Q45968869)

From Wikidata

Revision as of 02:27, 8 March 2019 by Renamerr (talk | contribs) (‎Changed Ukrainian description: наукова стаття, опублікована в червні 2009, #quickstatements; batch #8978 by User:Renamerr)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Cost-effectiveness of varenicline for smoking cessation.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19527093

Cost-effectiveness of varenicline for smoking cessation. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19527093

author name string

Hans Keiding

1

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19527093

publication date

1 June 2009

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19527093

Expert Review of Pharmacoeconomics & Outcomes Research

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19527093

9

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19527093

3

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19527093

215-221

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19527093

Regional, disease specific patterns of smoking-attributable mortality in 2000.

1 reference

https://api.crossref.org/works/10.1586%2FERP.09.19

21 January 2018

Short-term economic and health benefits of smoking cessation: myocardial infarction and stroke

1 reference

https://api.crossref.org/works/10.1586%2FERP.09.19

21 January 2018

Pharmacotherapy for smoking cessation

1 reference

https://api.crossref.org/works/10.1586%2FERP.09.19

21 January 2018

Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation

1 reference

https://api.crossref.org/works/10.1586%2FERP.09.19

21 January 2018

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1586%2FERP.09.19

21 January 2018

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1586%2FERP.09.19

21 January 2018

Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy

1 reference

https://api.crossref.org/works/10.1586%2FERP.09.19

21 January 2018

Cost-effectiveness of pharmacotherapies for nicotine dependence in primary care settings: a multinational comparison

1 reference

https://api.crossref.org/works/10.1586%2FERP.09.19

21 January 2018

The Health Care Costs of Smoking

1 reference

https://api.crossref.org/works/10.1586%2FERP.09.19

21 January 2018

Cost-utility analysis of varenicline versus existing smoking cessation strategies using the BENESCO Simulation model: application to a population of US adult smokers

1 reference

https://api.crossref.org/works/10.1586%2FERP.09.19

21 January 2018

Development of the health and economic consequences of smoking interactive model

1 reference

https://api.crossref.org/works/10.1586%2FERP.09.19

21 January 2018

Varenicline for tobacco dependence

1 reference

https://api.crossref.org/works/10.1586%2FERP.09.19

21 January 2018

Varenicline as compared to bupropion in smoking-cessation therapy--cost-utility results for Sweden 2003.

1 reference

https://api.crossref.org/works/10.1586%2FERP.09.19

21 January 2018

Cost-utility analysis of varenicline, an oral smoking-cessation drug, in Japan

1 reference

https://api.crossref.org/works/10.1586%2FERP.09.19

21 January 2018

Costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia

1 reference

https://api.crossref.org/works/10.1586%2FERP.09.19

21 January 2018

Modern medical support for smoking cessation

1 reference

https://api.crossref.org/works/10.1586%2FERP.09.19

21 January 2018

Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatment

1 reference

https://api.crossref.org/works/10.1586%2FERP.09.19

21 January 2018

Identifiers

10.1586/ERP.09.19

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19527093

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19527093

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45968869&oldid=877026846"